Effects of beta-adrenoceptor blocker nipradilol on renal microcirculation in a rat model: A comparative study with propranolol

Current Therapeutic Research - Clinical and Experimental

Volumn 59, Issue 3, 1998, Pages 179-186

  Kimura, Kenjiro ^a   Suzuki, Naoe ^a   Mise, Naobumi ^a   Ohba, Shigeyoshi ^a   Miyashita, Kazuhisa ^a   Tojo, Akihiro ^a   Hirata, Yasunobu ^a   Goto, Atsuo ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Arteriole; beta adrenoceptor blocker; Glomerulus; Hydronephrosis; Kidney; Nipradilol; Propranolol

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; NIPRADILOL; PROPRANOLOL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULUS; HYDRONEPHROSIS; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; MICROCIRCULATION; MICROSCOPY; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; VASODILATATION;

EID: 0031909889     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(98)85014-5     Document Type: Article

References (17)

1. Adachi T, Hori S, Miyazaki K, et al. Rapid increase in plasma nitrite concentration following intravenous administration of nipradilol. Eur J Pharmacol. 1995;286:201-204.
2. Chiba S, Tsukada M. Blocking effects of nipradilol on vasoconstrictor responses to periarterial nerve stimulation and alpha-adrenoceptor agonists in isolated and perfused canine mesenteric arteries. Pharmacology. 1987;35:112-120.
3. Imai S, Nakahara H, Nakazawa M, Takeda K. Adrenergic receptor effects and antihypertensive actions of beta-adrenoceptor-blocking agents with ancillary properties. Drugs. 1988;36(Suppl 6):10-19.
4. Nakagawa Y, Nakahara H, Chin WP, Imai S. Alpha-blockade and vasodilatation induced by nipradilol, arotinolol and labetalol in pithed rats. Jpn J Pharmacol. 1985;39:481-485.
5. Nanjo T, Kitamura K. Actions of nipradilol (K-351), a new alpha- and beta-adrenoceptor blocker, on the rabbit portal vein. Jpn J Pharmacol. 1984;35:359-369.
6. Haneda T, Ogawa Y, Akaishi T, et al. Efficacy of long-term treatment with nipradilol, a nitroester-containing beta-blocker, in patients with mild-to-moderate essential hypertension. Clin Ther. 1995;17:667-679.
7. Kawamura A, Fujiwara H, Ishida M, et al. Protective effects of nipradilol, isosorbide dinitrate, and bunazosin on coronary artery constriction induced by intracoronary injection of acetylcholine in pigs. Cardiovasc Res. 1990;24:1013-1019.
8. Igarashi J, Nishida M, Hoshida S, et al. Nipradilol, a nitric oxide releasing beta-receptor blocker, increases cGMP content in smooth muscle cells, but not in cardiac myocytes. Circulation. 1997;94:I-165. Abstract.
9. Steinhausen M, Snoei H, Parekh N, et al. Hydronephrosis: A new method to visualize vas afferens, efferens, and glomerular network. Kidney Int. 1983;23:794-806.
10. Steinhausen M, Blum M, Fleming JT, et al. Visualization of renal autoregulation in the split hydronephrotic kidney of rats. Kidney Int. 1989;35:1151-1160.
11. Kimura K, Tojo A, Hirata Y, et al. Effects of a calcium antagonist and an angiotensin II receptor antagonist on rat renal arterioles. Blood Press Suppl. 1994;5:71-74.
12. Kawashima K, Watanabe TX, Sokabe H. Pharmacodynamic and pharmacokinetic studies on prizidilol and nipradilol (K-351), antihypertensive drugs with combined vasodilator and beta-adrenoceptor blocking actions, in rabbits. Jpn J Pharmacol. 1984;36:519-526.
13. Sakanashi M, Takeo S, Ito H, et al. Effects of an antihypertensive agent, nipradilol, on isolated coronary artery of the dog. Pharmacology. 1984;29:241-246.
14. Nakahara H, Nakazawa M, Takeda K, Imai S. Role of the alpha-adrenergic blocking effect in the acute hypotensive effect of beta-adrenergic blocking drugs with alpha-blocking activities in conscious SHR. Jpn J Pharmacol. 1985;39:487-492.
15. Garg UC, Hassid A. Inhibition of rat mesangial cell mitogenesis by nitric oxide-generating vasodilators. Am J Physiol. 1989;257:F60-F66.
16. Koya D, Kikkawa R, Haneda M, et al. Nipradilol inhibits rat mesangial cell mitogenesis through the activation of soluble guanylate cyclase. Eur J Pharmacol. 1993;245:79-82.
17. Araki H, Itoh M, Nishi K. Effects of nipradilol on the microvascular tone of rat mesentery: Comparison with other beta-blockers and vasodilators. Arch Int Pharmacodyn Ther. 1992;318:47-54.